FKBP5 and Insulin resistance: Preclinical studies in animal models have shown that gene deletion or pharmacological inhibition of FKBP5 leads to reduced white adipose tissue mass, and protection from diet-induced weight gain, insulin resistance and hepatic steatosis8,9.